Hpv-associated Oropharyngeal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Hpv-associated Oropharyngeal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN) [Phase 2]
A Phase 2 trial assesses neoadjuvant chemotherapy combined with a PD-1 inhibitor for head and neck squamous cell carcinoma with the goal of …
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma [Phase 2]
A Phase 2 trial update evaluating de-escalation of radiotherapy to 30 Gy for select HPV-associated oropharyngeal squamous cell carcinoma. Th…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma [Phase 3]
A Phase 3 clinical trial evaluating PDS0101 in combination with pembrolizumab for HPV16-positive recurrent or metastatic head and neck squam…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Shortened Course Adjuvant Radiotherapy Following TORS [Phase 2]
Phase 2 clinical trial evaluating a shortened course of adjuvant radiotherapy following transoral robotic surgery for HPV-associated orophar…
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study [Phase 2]
This is a Phase 2 clinical trial (ReACT) evaluating risk-adapted therapy guided by circulating tumor HPV DNA in HPV-associated and HPV-posit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-11-13Clinical Trial Update: Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma [Phase 1, Phase 2]
A clinical trial evaluating cetuximab, cisplatin, and BYL719 for HPV-associated oropharyngeal squamous cell carcinoma has been withdrawn.